A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination With Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants With First-Line Metastatic Pancreatic Ductal Adenocarcinoma
Clinical trial NCT07490301 · RECRUITING
Trial details
- NCT number
- NCT07490301
- Sponsor
- AbbVie
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-30
- Primary completion
- 2031-06-01
- Enrollment
- 900
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.